Passion Struck with John R. Miles

Alzheimer’s Research, Doctored Data, and the Human Cost | Charles Piller – EP 722

Jan 29, 2026
Charles Piller, investigative science journalist and author of Doctored, uncovers how a pivotal 2006 study helped cement the amyloid hypothesis for Alzheimer’s. The conversation traces manipulated images, slow institutional responses, whistleblower struggles, and the human cost of entrenched research incentives. It also points to new lines of inquiry and the role of watchdog reporting in preserving scientific integrity.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
INSIGHT

Amyloid Hypothesis Shaped Decades Of Research

  • The amyloid hypothesis links amyloid plaque accumulation to neuron death and dementia and drove decades of research and funding.
  • Drugs that remove plaques repeatedly failed to stop cognitive decline, exposing gaps in the hypothesis.
ANECDOTE

Seminal 2006 Study Later Questioned

  • A 2006 University of Minnesota study isolated amyloid beta*56 and reported memory loss in rodents, reviving amyloid confidence.
  • Matthew Schrag later found doctored images in that seminal paper, triggering scrutiny and eventual retraction.
INSIGHT

Slow Institutional Response Prolongs Harm

  • Scientific journals and universities are often slow and secretive when handling misconduct allegations.
  • That sluggishness lets flawed studies influence the field far longer than necessary.
Get the Snipd Podcast app to discover more snips from this episode
Get the app